描述你的成果Describe your work
机制、阶段、已有数据和权属,用平实的话写下来。没有专利也可以提交。Mechanism, stage, data and ownership in plain words. No patent required.
把实验室里的早期成果交给 Tula。几分钟写清楚,AI 评估离概念验证还有多远,Tula 团队为你对接合适的产业方。Bring your early-stage work to Tula. Describe it in minutes, see how far it is from proof of concept, and let the Tula team introduce you to the right industry partners.
很多好的早期研究,停在了论文和实验记录里。不是不够好,而是产业看不懂、找不到、不放心。Tula 把它们写成产业读得懂的语言,并把公开的节奏,交还到你手里。A great deal of good early research stops at the paper and the lab notebook. Not because it isn't good, but because industry can't read it, can't find it, or can't trust it yet. Tula puts it in the language industry reads, and keeps the pace of disclosure in your hands.
用平实的话填写机制、阶段、数据与权属,没有专利也可以提交。Mechanism, stage, data and ownership in plain words. No patent required.
初步结论更早返回,先看到离概念验证还有多远。A first read comes back sooner, showing the distance to proof of concept.
科学、数据、竞品、可交易性,每一项都附理由。Science, data, landscape and dealability, each with a reason.
机制、阶段、已有数据和权属,用平实的话写下来。没有专利也可以提交。Mechanism, stage, data and ownership in plain words. No patent required.
离 POC 还有多远、数据可信度,以及先改哪里。四个维度评分,每项附理由。How far from POC, how credible the data is and what to fix first. Four axes, each with a reason.
成果以匿名简介进入管线库,机构名称和课题组信息默认遮住。Your work enters the pipeline as an anonymous brief. Your institution and lab stay hidden.
把匿名简介带给需求相符的药企 BD 与投资方,每一步都先征求你的意见。We take the brief to pharma BD teams and investors who fit, checking with you at every step.
每份 CDA 由你批准,数据室逐人授权、带水印并留有日志,条款由你和产业方直接谈。You approve each CDA. The data room is granted per person, watermarked and logged; terms are yours to agree.
产业方最先看到的一页,机构名称默认遮住。The first page industry sees, with your name hidden by default.
只给你看:四维评分和理由、离 POC 的距离、下一步。Just for you: four scored axes, distance to POC, next steps.
离 POC 还差一项动物药效研究One animal efficacy study from POC
机制有差异化,体外与药代数据扎实。缺一项动物药效研究。A distinct mechanism with solid in vitro and PK data. One animal efficacy study is missing.
三重激动机制,同类少见Triple agonism, few peers
缺体内药效No in vivo efficacy yet
赛道拥挤,但机制有区分度Crowded field, distinct mechanism
权属清晰,产业关注度高Clear rights, strong industry interest
你的成果先以匿名形式出现。是否继续、对谁开放、开放多少,都由你来点头。Your work appears anonymously first. Whether to go further, with whom and how much is always your call.
产业方先看到的只有简介,不含机构名称和课题组信息。Industry sees the brief first, without your institution or lab.
对方申请进一步了解,由你决定是否同意。签保密协议、公开名称、开放完整数据,每一步都要你点头。When someone asks to learn more, you decide. An NDA, your name, the full data: each step needs your yes.
任何时候都可以撤回已开放的权限。数据室逐人授权、带水印并留有日志。Withdraw access whenever you like. The data room is granted per person, watermarked and logged.
Vinda AI 是一个独立产品,在新标签页打开,Tula 不会把你的上架信息传给它。Vinda AI is a separate product. It opens in a new tab and Tula does not send it your listing details.
“好的早期研究,不该停在实验室里。我们想让它被产业读懂,也让研究者守住每一步的主动权。”“Good early research shouldn't stop at the lab. We want industry to understand it, and researchers to stay in control of every step.”
把论文之外的成果,变成产业能评估的东西。Turn work beyond the paper into something industry can assess.
用同一份标准整理多个项目。Present many projects to one standard.
一份报告讲清管线,少做重复尽调。One report that explains the pipeline.
法规路径规划;化学、生产与质量控制。Regulatory path; chemistry, manufacturing and controls.
药理研究支持。Pharmacology study support.
好项目逐案协商;收费服务开工前谈定范围和报价。Case by case; paid work is scoped and quoted first.
面向管线持有方的对话式助手。A chat assistant for pipeline owners.
Telegram @Lance_xyz
没找到答案?在 Telegram 联系我们:Something else? Message us on Telegram: @Lance_xyz
可以。需要的话,Tula 可以协助先行申请。我们也会核查主要地区的专利与抢注风险。Yes. If you want one, Tula can help you file first, and we check key regions for patent and squatting risks.
Tula 团队对接的产业方只会看到匿名简介。机构名称和完整资料,只在你批准、对方签署保密协议之后才开放。Industry contacts introduced by the Tula team see only the anonymous brief. Your name and full materials open after you approve and they sign an NDA.
你会立刻看到初步判断,通常 2–3 个工作日内收到完整报告。之后由 Tula 团队判断适合对接哪些产业方,并先征求你的意见。You get a first read right away and the full report within 2–3 business days. The Tula team then decides which industry contacts fit, and checks with you first.
提交和就绪度报告没有强制费用。FDA、CMC 等协助服务,会在开工前与你谈定范围和报价。Submitting and the readiness report carry no obligation. Help such as FDA or CMC work is scoped and quoted with you before it starts.
这在高校很常见。常见做法是首付折让、后端以销售分成回收;Tula 也可以承担部分开发,按承担的工作分成。That is common for university labs. A typical deal is a smaller upfront with royalties later; Tula can also take on part of the work and share in proportion.
由你和产业方直接谈。Tula 不定价,也不替你成交。You and the industry party, directly. Tula does not set the price or close on your behalf.